Annual EBIT
-$39.27 M
+$8.13 M+17.15%
December 31, 2023
Summary
- As of February 7, 2025, GLYC annual earnings before interest & taxes is -$39.27 million, with the most recent change of +$8.13 million (+17.15%) on December 31, 2023.
- During the last 3 years, GLYC annual EBIT has risen by +$12.23 million (+23.75%).
- GLYC annual EBIT is now -1180.46% below its all-time high of $3.63 million, reached on December 31, 2012.
Performance
GLYC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.72 M
+$4.64 M+44.76%
September 30, 2024
Summary
- As of February 7, 2025, GLYC quarterly earnings before interest & taxes is -$5.72 million, with the most recent change of +$4.64 million (+44.76%) on September 30, 2024.
- Over the past year, GLYC quarterly EBIT has increased by +$3.87 million (+40.34%).
- GLYC quarterly EBIT is now -155.08% below its all-time high of $10.39 million, reached on June 30, 2015.
Performance
GLYC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$36.78 M
+$4.09 M+10.01%
September 30, 2024
Summary
- As of February 7, 2025, GLYC TTM earnings before interest & taxes is -$36.78 million, with the most recent change of +$4.09 million (+10.01%) on September 30, 2024.
- Over the past year, GLYC TTM EBIT has increased by +$2.49 million (+6.34%).
- GLYC TTM EBIT is now -2038.81% below its all-time high of $1.90 million, reached on March 31, 2013.
Performance
GLYC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GLYC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.1% | +40.3% | +6.3% |
| 3 y3 years | +23.8% | +67.2% | +42.0% |
| 5 y5 years | +23.8% | +67.2% | +42.0% |
GLYC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.1% | at high | +67.2% | at high | +42.4% |
| 5 y | 5-year | at high | +38.1% | at high | +67.2% | at high | +42.4% |
| alltime | all time | -1180.5% | +38.1% | -155.1% | +67.2% | -2038.8% | +42.4% |
GlycoMimetics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.72 M(-44.8%) | -$36.78 M(-10.0%) |
| Jun 2024 | - | -$10.36 M(-6.8%) | -$40.88 M(+3.6%) |
| Mar 2024 | - | -$11.12 M(+15.9%) | -$39.45 M(+0.4%) |
| Dec 2023 | -$39.27 M(-17.1%) | -$9.59 M(-2.3%) | -$39.27 M(-2.6%) |
| Sep 2023 | - | -$9.81 M(+9.9%) | -$40.31 M(+2.7%) |
| Jun 2023 | - | -$8.93 M(-18.4%) | -$39.26 M(-10.1%) |
| Mar 2023 | - | -$10.94 M(+3.0%) | -$43.68 M(-7.8%) |
| Dec 2022 | -$47.40 M(-25.3%) | -$10.62 M(+21.1%) | -$47.40 M(-12.6%) |
| Sep 2022 | - | -$8.77 M(-34.3%) | -$54.21 M(-13.7%) |
| Jun 2022 | - | -$13.35 M(-8.9%) | -$62.78 M(-1.6%) |
| Mar 2022 | - | -$14.66 M(-15.9%) | -$63.83 M(+0.6%) |
| Dec 2021 | -$63.45 M(+23.2%) | -$17.43 M(+0.5%) | -$63.45 M(+3.0%) |
| Sep 2021 | - | -$17.34 M(+20.4%) | -$61.59 M(+6.2%) |
| Jun 2021 | - | -$14.40 M(+0.9%) | -$57.98 M(+0.5%) |
| Mar 2021 | - | -$14.28 M(-8.3%) | -$57.68 M(+12.0%) |
| Dec 2020 | -$51.51 M(-16.1%) | -$15.57 M(+13.4%) | -$51.51 M(+0.5%) |
| Sep 2020 | - | -$13.73 M(-2.7%) | -$51.28 M(-0.7%) |
| Jun 2020 | - | -$14.11 M(+74.0%) | -$51.65 M(-5.0%) |
| Mar 2020 | - | -$8.11 M(-47.1%) | -$54.37 M(-11.4%) |
| Dec 2019 | -$61.39 M(+19.2%) | -$15.34 M(+8.7%) | -$61.39 M(+0.6%) |
| Sep 2019 | - | -$14.11 M(-16.1%) | -$61.01 M(+2.7%) |
| Jun 2019 | - | -$16.82 M(+11.1%) | -$59.43 M(+8.5%) |
| Mar 2019 | - | -$15.13 M(+1.2%) | -$54.76 M(+6.3%) |
| Dec 2018 | -$51.50 M | -$14.96 M(+19.5%) | -$51.50 M(+11.8%) |
| Sep 2018 | - | -$12.52 M(+3.0%) | -$46.08 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$12.15 M(+2.3%) | -$41.74 M(+18.2%) |
| Mar 2018 | - | -$11.88 M(+24.5%) | -$35.32 M(+12.4%) |
| Dec 2017 | -$33.93 M(+6.3%) | -$9.54 M(+16.6%) | -$31.41 M(+3.9%) |
| Sep 2017 | - | -$8.18 M(+42.9%) | -$30.24 M(+1.0%) |
| Jun 2017 | - | -$5.72 M(-28.2%) | -$29.94 M(-7.3%) |
| Mar 2017 | - | -$7.97 M(-4.6%) | -$32.31 M(+1.2%) |
| Dec 2016 | -$31.91 M(+149.6%) | -$8.36 M(+6.0%) | -$31.91 M(-1.6%) |
| Sep 2016 | - | -$7.89 M(-2.5%) | -$32.44 M(+2.3%) |
| Jun 2016 | - | -$8.09 M(+6.8%) | -$31.73 M(+139.5%) |
| Mar 2016 | - | -$7.57 M(-14.8%) | -$13.25 M(+3.6%) |
| Dec 2015 | -$12.78 M(+14.8%) | -$8.89 M(+23.9%) | -$12.78 M(+13.2%) |
| Sep 2015 | - | -$7.17 M(-169.0%) | -$11.30 M(+4.4%) |
| Jun 2015 | - | $10.39 M(-246.0%) | -$10.82 M(-17.7%) |
| Mar 2015 | - | -$7.11 M(-3.9%) | -$13.15 M(+18.0%) |
| Dec 2014 | -$11.14 M(+5.0%) | -$7.40 M(+10.4%) | -$11.14 M(+46.4%) |
| Sep 2014 | - | -$6.70 M(-183.1%) | -$7.61 M(+65.0%) |
| Jun 2014 | - | $8.06 M(-257.9%) | -$4.61 M(-71.5%) |
| Mar 2014 | - | -$5.11 M(+32.0%) | -$16.17 M(+52.5%) |
| Dec 2013 | -$10.61 M(-391.8%) | -$3.87 M(+4.5%) | -$10.61 M(+73.2%) |
| Sep 2013 | - | -$3.70 M(+5.8%) | -$6.12 M(+282.9%) |
| Jun 2013 | - | -$3.50 M(-862.3%) | -$1.60 M(-184.3%) |
| Mar 2013 | - | $458.70 K(-25.4%) | $1.90 M(+31.9%) |
| Dec 2012 | $3.63 M(-159.7%) | $614.60 K(-25.4%) | $1.44 M(+74.6%) |
| Sep 2012 | - | $824.00 K | $824.00 K |
| Dec 2011 | -$6.08 M | - | - |
FAQ
- What is GlycoMimetics annual earnings before interest & taxes?
- What is the all time high annual EBIT for GlycoMimetics?
- What is GlycoMimetics annual EBIT year-on-year change?
- What is GlycoMimetics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GlycoMimetics?
- What is GlycoMimetics quarterly EBIT year-on-year change?
- What is GlycoMimetics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GlycoMimetics?
- What is GlycoMimetics TTM EBIT year-on-year change?
What is GlycoMimetics annual earnings before interest & taxes?
The current annual EBIT of GLYC is -$39.27 M
What is the all time high annual EBIT for GlycoMimetics?
GlycoMimetics all-time high annual earnings before interest & taxes is $3.63 M
What is GlycoMimetics annual EBIT year-on-year change?
Over the past year, GLYC annual earnings before interest & taxes has changed by +$8.13 M (+17.15%)
What is GlycoMimetics quarterly earnings before interest & taxes?
The current quarterly EBIT of GLYC is -$5.72 M
What is the all time high quarterly EBIT for GlycoMimetics?
GlycoMimetics all-time high quarterly earnings before interest & taxes is $10.39 M
What is GlycoMimetics quarterly EBIT year-on-year change?
Over the past year, GLYC quarterly earnings before interest & taxes has changed by +$3.87 M (+40.34%)
What is GlycoMimetics TTM earnings before interest & taxes?
The current TTM EBIT of GLYC is -$36.78 M
What is the all time high TTM EBIT for GlycoMimetics?
GlycoMimetics all-time high TTM earnings before interest & taxes is $1.90 M
What is GlycoMimetics TTM EBIT year-on-year change?
Over the past year, GLYC TTM earnings before interest & taxes has changed by +$2.49 M (+6.34%)